Standard therapies for CRSwNP include topical corticosteroids and NP surgery [42]; however, biological anti IL-5 therapy, including mepolizumab, reslizumab, and benralizumab, may decrease NP size and improve nasal symptoms. The gene discussed is IL5; the disease is chronic rhinosinusitis with nasal polyps.